Loading…
Pharmaids Pharmaceuticals (BSE 524572)₹30.00+5.01%Pharmaceuticals
Pharmaids Pharmaceuticals is compared with the 10 closest in size in Pharmaceuticals (229 companies in the industry). It has a ROCE of −18.4% against a peer median of 7.0%, and latest-quarter sales growth of −38.2% against a peer median of 30.5%. By market cap it is #7 of 11 in this set.
As of · Peer set: 10 closest in size in Pharmaceuticals
| Company | M-cap (₹ Cr) | P/E | ROCE % | ROE % | Debt / equity | Div. yield % | Sales (₹ Cr) | Net profit (₹ Cr) | Qtr sales growth % | Qtr profit growth % | Compare |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BALAXI PHARMACEUTICALS | 125 | 55.3 | 3.0 | 0.6 | 0.23 | 0.0 | 270 | 1 | 14.1 | 336.7 | vs BSE 524572 |
| Parnax Lab | 125 | 14.0 | 14.1 | 14.4 | 0.87 | 0.0 | 249 | 12 | 6.4 | −86.6 | vs BSE 524572 |
| Godavari Drugs | 122 | 24.2 | 7.0 | 6.4 | 1.00 | 0.0 | 106 | 4 | 30.1 | 45.5 | vs BSE 524572 |
| Alpa Laboratories | 119 | 28.6 | 9.1 | 8.3 | 0.02 | 0.0 | 106 | 15 | 25.3 | −91.6 | vs BSE 524572 |
| Makers Laboratories | 111 | 14.9 | 9.0 | 3.2 | 0.05 | 0.0 | 141 | 8 | 41.0 | 1,064.4 | vs BSE 524572 |
| Tyche Industries | 109 | 15.9 | 6.8 | 5.0 | 0.00 | 2.8 | 54 | 7 | 31.0 | 22.1 | vs BSE 524572 |
| Pharmaids Pharmaceuticals | 106 | — | −18.4 | −26.5 | 0.49 | 0.0 | 28 | −12 | −38.2 | — | — |
| Veerhealth Care | 103 | 177.3 | 7.2 | 3.0 | 0.20 | 0.0 | 33 | 1 | 198.0 | — | vs BSE 524572 |
| Concord Drugs | 96 | 44.3 | 5.5 | 2.6 | 0.28 | 0.0 | 79 | 1 | 53.9 | 900.0 | vs BSE 524572 |
| Cian Healthcare | 94 | — | −16.1 | −49.2 | 3.38 | 0.0 | 28 | −23 | 41.6 | — | vs BSE 524572 |
| Vaishali Pharma | 91 | 23.4 | 7.9 | 6.0 | 0.28 | 0.0 | 109 | 4 | — | — | vs BSE 524572 |
| Peer median | 109 | 24.2 | 7.0 | 3.2 | 0.28 | 0.0 | 106 | 4 | 30.5 | 45.5 |
Listed companies closest to Pharmaids Pharmaceuticals in Pharmaceuticals include BALAXI PHARMACEUTICALS, Parnax Lab, Godavari Drugs, Alpa Laboratories, Makers Laboratories, Tyche Industries, Veerhealth Care, Concord Drugs.
BALAXI PHARMACEUTICALS, with a market cap of ₹125 Cr.
Pharmaids Pharmaceuticals' return on capital employed is −18.4%, below the peer median of 7.0%.